PCaTest has already proven a superior predictive ability in comparison with other genetic prognostic tests Cytodyn in the process of acquiring PCaTest developer ProstaGene and will launch a clinical study once the transaction is complete Prostate cancer is the second-most common type of cancer among American men, with almost 165,000 new cases expected this year […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.